Press Releases
FDA approves Herceptin for HER2-positive metastatic stomach cancer
Roche announced the U.S. Food and Drug Administration (FDA) has approved Herceptin (trastuzumab) in combination with chemotherapy (cisplatin plus either capecitabine or 5-fluorouracil ) for...
Press Releases
Amylin, Lilly and Alkermes Announce Receipt of Complete Response...
Amylin Pharmaceuticals, Inc. Eli Lilly and Company and Alkermes, Inc.announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding...
Press Releases
Endress+Hauser Announces Collaboration with SAP as a Core Partner...
SAP Research is the global technology research unit of SAP. The group significantly contributes to SAP's product portfolio and extends its leading position...
Press Releases
NeurogesX to Pursue Expanded U.S Label for Qutenza(R) 8%...
NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced plans to pursue a U.S. label expansion for Qutenza(R)...
Press Releases
Italvacuum to Attend India CHEM 2010
We are pleased to announce that Italvacuum is participating India CHEM 2010, the largest event of the chemical and petrochemical industry in India....
Press Releases
AVEVA to Exhibit at Drug Delivery Partnerships 2011
Aveva Drug Delivery Systems is pleased to announce that it will exhibit at Drug Delivery Partnerships on 26-28 January 2011 in Miami, Florida,...
Press Releases
APR and Labtec enter into exclusive License Agreement with...
APR and its development partner Labtec have entered into an exclusive licensing agreement with the leading European pharmaceutical company Ferrer Internacional (Ferrer) for the promotion,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.